|
US7825121B2
(en)
*
|
1999-05-04 |
2010-11-02 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
WO2002079157A1
(en)
*
|
2001-03-29 |
2002-10-10 |
Schering Corporation |
Aryl oxime-piperazines useful as ccr5 antagonists
|
|
PL364560A1
(en)
|
2001-03-29 |
2004-12-13 |
Schering Corporation |
Ccr5 antagonists useful for treating aids
|
|
US6943251B2
(en)
*
|
2001-11-29 |
2005-09-13 |
Schering Corporation |
Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
|
|
EP2311818B1
(en)
|
2002-02-28 |
2013-01-16 |
Novartis AG |
Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug
|
|
JP4671091B2
(ja)
*
|
2002-03-18 |
2011-04-13 |
東レ・ファインケミカル株式会社 |
１−置換−２−メチルピペラジンの製造方法
|
|
AU2003224777A1
(en)
*
|
2002-03-29 |
2003-10-20 |
Schering Corporation |
Synthesis of piperidine and piperazine compounds as ccr5 antagonists
|
|
EP1490346B1
(en)
|
2002-03-29 |
2009-12-02 |
Schering Corporation |
Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
|
|
EP1498125A4
(en)
*
|
2002-04-24 |
2008-08-20 |
Takeda Pharmaceutical |
USE OF ANTI-CCR ANTAGONISM COMPOUNDS
|
|
JP2003335737A
(ja)
|
2002-05-21 |
2003-11-28 |
Central Glass Co Ltd |
光学活性（ｒ）−１−（４−トリフルオロメチルフェニル）エチルアミン
|
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
WO2004054616A1
(ja)
*
|
2002-12-13 |
2004-07-01 |
Ono Pharmaceutical Co., Ltd. |
ケモカイン受容体の強結合部位に結合するアンタゴニストおよびアゴニスト
|
|
PE20040769A1
(es)
*
|
2002-12-18 |
2004-11-06 |
Schering Corp |
Derivados de piperidina utiles como antagonisas ccr5
|
|
WO2004080966A1
(ja)
|
2003-03-14 |
2004-09-23 |
Ono Pharmaceutical Co., Ltd. |
含窒素複素環誘導体およびそれらを有効成分とする薬剤
|
|
JPWO2004092136A1
(ja)
*
|
2003-04-18 |
2006-07-06 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその用途
|
|
WO2004092169A1
(ja)
|
2003-04-18 |
2004-10-28 |
Ono Pharmaceutical Co., Ltd. |
スピロピペリジン化合物およびその医薬用途
|
|
TW200519106A
(en)
|
2003-05-02 |
2005-06-16 |
Novartis Ag |
Organic compounds
|
|
GB0313661D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Avecia Ltd |
Process
|
|
RU2006100190A
(ru)
*
|
2003-06-13 |
2006-08-10 |
Шеринг Акциенгезельшафт (De) |
Производные хинолиламида в качестве антагонистов ccr-5
|
|
EP1644366A1
(en)
|
2003-06-30 |
2006-04-12 |
Schering Corporation |
Mch antagonists for the treatment of obesity
|
|
JP4757802B2
(ja)
|
2003-11-03 |
2011-08-24 |
シェーリング コーポレイション |
ケモカインレセプターの阻害剤として有用なビピペリジニル誘導体
|
|
GB0329284D0
(en)
*
|
2003-12-18 |
2004-01-21 |
Avecia Ltd |
Process
|
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
CA2554465A1
(en)
*
|
2004-02-05 |
2005-08-25 |
Schering Corporation |
Piperidine derivatives useful as ccr3 antagonists
|
|
WO2005075484A2
(en)
|
2004-02-10 |
2005-08-18 |
F. Hoffmann-La Roche Ag |
Chemokine ccr5 receptor modulators
|
|
ZA200607637B
(en)
|
2004-03-05 |
2008-05-28 |
Nissan Chemical Ind Ltd |
Isoxazoline-substituted benzamide compound and noxious organism control agent
|
|
EP1734966B1
(en)
*
|
2004-04-13 |
2013-07-31 |
Incyte Corporation |
Piperazinylpiperidine derivatives as chemokine receptor antagonists
|
|
CA2569910A1
(en)
|
2004-06-09 |
2005-12-22 |
Eun Kyung Lee |
Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds
|
|
GB0417804D0
(en)
*
|
2004-08-10 |
2004-09-15 |
Novartis Ag |
Organic compounds
|
|
MX2007002886A
(es)
*
|
2004-09-13 |
2007-05-16 |
Ono Pharmaceutical Co |
Derivado heterociclico que contiene nitrogeno y un farmaco que contiene el mismo como el ingrediente activo.
|
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
|
KR101351209B1
(ko)
|
2004-12-03 |
2014-02-06 |
머크 샤프 앤드 돔 코포레이션 |
Ｃｂ1 길항제로서 치환된 피페라진
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
US7880002B2
(en)
|
2004-12-29 |
2011-02-01 |
Millennium Pharmaceuticals, Inc. |
Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
|
|
JP2008526862A
(ja)
|
2005-01-06 |
2008-07-24 |
シェーリング コーポレイション |
ピペラジン化合物の薬学的な塩の調製
|
|
KR20070107060A
(ko)
|
2005-02-16 |
2007-11-06 |
쉐링 코포레이션 |
Ｃｘｃｒ3 길항제 활성을 갖는 피라지닐 치환된피페라진-피페리딘
|
|
CN101189238A
(zh)
*
|
2005-02-16 |
2008-05-28 |
先灵公司 |
具有cxcr3拮抗剂活性的哌嗪-哌啶
|
|
MX2007010067A
(es)
|
2005-02-16 |
2007-12-07 |
Schering Corp |
Compuestos heterociclicos novedosos sustituidos con piridina o fenilo con actividad antagonista de cxcr3.
|
|
CN101203509B
(zh)
|
2005-02-16 |
2013-05-08 |
默沙东公司 |
具有cxcr3拮抗剂活性的胺-连接的吡啶基和苯基取代的哌嗪-哌啶
|
|
WO2006088919A2
(en)
*
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
CN101163695A
(zh)
*
|
2005-02-23 |
2008-04-16 |
先灵公司 |
用作趋化因子受体抑制剂的哌啶基哌嗪衍生物
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
WO2006129679A1
(ja)
|
2005-05-31 |
2006-12-07 |
Ono Pharmaceutical Co., Ltd. |
スピロピペリジン化合物およびその医薬用途
|
|
WO2006128803A1
(en)
|
2005-06-02 |
2006-12-07 |
F. Hoffmann-La Roche Ag |
Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
|
|
US7665658B2
(en)
|
2005-06-07 |
2010-02-23 |
First Data Corporation |
Dynamic aggregation of payment transactions
|
|
BRPI0617720A2
(pt)
|
2005-10-19 |
2011-08-02 |
Hoffmann La Roche |
compostos inibidores de nnrt de fenil-acetamida, usos dos referidos compostos e composição farmacêutica que os contém
|
|
EP2532679B1
(en)
|
2005-10-21 |
2017-04-12 |
Novartis AG |
Human antibodies against il13 and therapeutic uses
|
|
US8318931B2
(en)
|
2005-10-28 |
2012-11-27 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonists and use thereof
|
|
US8168783B2
(en)
|
2005-11-18 |
2012-05-01 |
Ono Pharmaceutical Co., Ltd. |
Chemokine receptor antagonists and use thereof
|
|
AR063656A1
(es)
*
|
2005-11-30 |
2009-02-11 |
Schering Corp |
Composiciones que comprenden una combinacion de antagonistas de ccr5 y cxcr4
|
|
GB0525671D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP1973877A2
(en)
|
2006-01-18 |
2008-10-01 |
Schering Corporation |
Cannibinoid receptor modulators
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
CA2644368A1
(en)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
|
MY146645A
(en)
|
2006-04-21 |
2012-09-14 |
Novartis Ag |
Purine derivatives for use as adenosin a2a receptor agonists
|
|
WO2007132846A1
(ja)
|
2006-05-16 |
2007-11-22 |
Ono Pharmaceutical Co., Ltd. |
保護されていてもよい酸性基を含有する化合物およびその用途
|
|
US20090325992A1
(en)
|
2006-07-31 |
2009-12-31 |
Ono Pharmaceutical Co., Ltd. |
Compound having cyclic group bound thereto through spiro binding and use thereof
|
|
DE602007013573D1
(de)
|
2006-08-16 |
2011-05-12 |
Hoffmann La Roche |
Nicht-nukleosidische reverse-transkriptase-hemmer
|
|
CA2664378A1
(en)
|
2006-09-29 |
2008-04-03 |
Novartis Ag |
Pyrazolopyrimidines as pi3k lipid kinase inhibitors
|
|
KR101475091B1
(ko)
|
2006-12-13 |
2014-12-22 |
에프. 호프만-라 로슈 아게 |
비뉴클레오시드 역전사 효소 억제제로서 2-(피페리딘-4-일)-4-페녹시- 또는 페닐아미노-피리미딘 유도체
|
|
GB0625523D0
(en)
*
|
2006-12-21 |
2007-01-31 |
Ge Healthcare Ltd |
In vivo imaging agents
|
|
EA016199B1
(ru)
|
2007-01-10 |
2012-03-30 |
Айрм Ллк |
Соединения и композиции как ингибиторы активирующей канал протеазы
|
|
UA100684C2
(uk)
*
|
2007-03-15 |
2013-01-25 |
Новартіс Аг |
Похідні бензилу та піридинілу як модулятори сигнального шляху hedgehog
|
|
CA2682639A1
(en)
|
2007-03-29 |
2008-10-09 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
JP5244904B2
(ja)
|
2007-05-07 |
2013-07-24 |
ノバルティス アーゲー |
有機化合物
|
|
EP2155689B1
(en)
|
2007-05-31 |
2015-07-08 |
Boehringer Ingelheim International GmbH |
Ccr2 receptor antagonists and uses thereof
|
|
JP2010540584A
(ja)
|
2007-10-01 |
2010-12-24 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｃｃｒ受容体アンタゴニストとしてのｎ−複素環ビアリールカルボキサミド類
|
|
ES2654395T3
(es)
|
2007-12-10 |
2018-02-13 |
Novartis Ag |
Análogos de amilorida espirocíclicos como bloqueantes de ENaC
|
|
EP2259772A2
(en)
*
|
2008-02-29 |
2010-12-15 |
Schering Corporation |
Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
WO2009128947A1
(en)
*
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
AU2009256645A1
(en)
|
2008-06-10 |
2009-12-17 |
Novartis Ag |
Pyrazine derivatives as epithelial sodium channel blockers
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
EA020548B1
(ru)
|
2008-12-19 |
2014-12-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
|
|
WO2010088335A1
(en)
|
2009-01-29 |
2010-08-05 |
Novartis Ag |
Substituted benzimidazoles for the treatment of astrocytomas
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
BR112012003262A8
(pt)
|
2009-08-12 |
2016-05-17 |
Novartis Ag |
compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
|
|
BR112012003709B1
(pt)
|
2009-08-17 |
2021-05-18 |
Intellikine Llc |
compostos heterocíclicos e usos dos mesmos
|
|
KR20120089463A
(ko)
|
2009-08-20 |
2012-08-10 |
노파르티스 아게 |
헤테로시클릭 옥심 화합물
|
|
EP2490687A1
(en)
|
2009-10-22 |
2012-08-29 |
Vertex Pharmaceuticals Incorporated |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
EP2513086B1
(en)
*
|
2009-12-17 |
2015-04-29 |
Boehringer Ingelheim International GmbH |
Novel antagonists for ccr2 and uses thereof
|
|
ES2524829T3
(es)
|
2009-12-17 |
2014-12-12 |
Boehringer Ingelheim International Gmbh |
Nuevos antagonistas del receptor CCR2 y usos de los mismos
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
US8946218B2
(en)
|
2010-05-12 |
2015-02-03 |
Boehringer Ingelheim International Gmbh |
CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
EP2569298B1
(en)
|
2010-05-12 |
2015-11-25 |
Boehringer Ingelheim International GmbH |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
JP5647339B2
(ja)
|
2010-05-17 |
2014-12-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｃｒ２アンタゴニスト及びこれらの使用
|
|
US9018212B2
(en)
|
2010-05-25 |
2015-04-28 |
Boehringer Ingelheim International Gmbh |
Pyridazine carboxamides as CCR2 receptor antagonists
|
|
EP2576538B1
(en)
|
2010-06-01 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
New CCR2 antagonists
|
|
ES2622519T3
(es)
|
2010-07-14 |
2017-07-06 |
Novartis Ag |
Componentes heterocíclicos agonistas del receptor IP
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
WO2012107500A1
(en)
|
2011-02-10 |
2012-08-16 |
Novartis Ag |
[1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
|
JP5808826B2
(ja)
|
2011-02-23 |
2015-11-10 |
インテリカイン， エルエルシー |
複素環化合物およびその使用
|
|
WO2013010839A1
(en)
|
2011-07-15 |
2013-01-24 |
Boehringer Ingelheim International Gmbh |
Novel and selective ccr2 antagonists
|
|
US20140271680A1
(en)
|
2011-08-12 |
2014-09-18 |
Universite Paris-Est Creteil Val De Marne |
Methods and pharmaceutical compositions for treatment of pulmonary hypertension
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
WO2013038362A1
(en)
|
2011-09-15 |
2013-03-21 |
Novartis Ag |
6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase
|
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
|
WO2013038390A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
ES2558457T3
(es)
|
2011-09-16 |
2016-02-04 |
Novartis Ag |
Compuestos heterocíclicos para el tratamiento de fibrosis quística
|
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
US9174994B2
(en)
|
2011-11-23 |
2015-11-03 |
Intellikine, Llc |
Enhanced treatment regimens using mTor inhibitors
|
|
EP2802583A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
Fused piperidines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
EP2802582A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
Fused dihydropyrido [2,3 -b]pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
AR089698A1
(es)
|
2012-01-13 |
2014-09-10 |
Novartis Ag |
Compuestos heterociclicos antagonistas del receptor ip
|
|
WO2013105066A1
(en)
|
2012-01-13 |
2013-07-18 |
Novartis Ag |
Salts of an ip receptor agonist
|
|
US9115129B2
(en)
|
2012-01-13 |
2015-08-25 |
Novartis Ag |
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists
|
|
EP2802581A1
(en)
|
2012-01-13 |
2014-11-19 |
Novartis AG |
7,8- dihydropyrido [3, 4 - b]pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
|
CN104245701A
(zh)
|
2012-04-03 |
2014-12-24 |
诺华有限公司 |
有酪氨酸激酶抑制剂的组合产品和其应用
|
|
AU2013340559B2
(en)
|
2012-10-29 |
2018-03-15 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
JP2016507582A
(ja)
|
2013-02-13 |
2016-03-10 |
ノバルティス アーゲー |
Ｉｐ受容体アゴニスト複素環式化合物
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
EP2968340A4
(en)
|
2013-03-15 |
2016-08-10 |
Intellikine Llc |
COMBINING KINASE INHIBITORS AND USES THEREOF
|
|
WO2015084804A1
(en)
|
2013-12-03 |
2015-06-11 |
Novartis Ag |
Combination of mdm2 inhibitor and braf inhibitor and their use
|
|
BR112016023967A2
(pt)
|
2014-04-24 |
2017-08-15 |
Novartis Ag |
derivados de pirazina como inibidores de fosfatidilinositol 3-cinase
|
|
EP3134397A1
(en)
|
2014-04-24 |
2017-03-01 |
Novartis AG |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
MX2016013981A
(es)
|
2014-04-24 |
2016-11-15 |
Novartis Ag |
Derivados de amino-piridina como inhibidores de fosfatidil-inositol-3-cinasa.
|
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
|
JP6526789B2
(ja)
|
2014-07-31 |
2019-06-05 |
ノバルティス アーゲー |
組み合わせ療法
|
|
CN107108581B
(zh)
*
|
2014-08-21 |
2020-06-23 |
百时美施贵宝公司 |
作为强效rock抑制剂的回接苯甲酰胺衍生物
|
|
JP6917910B2
(ja)
|
2015-07-02 |
2021-08-11 |
セントレクシオン セラピューティクス コーポレイション |
（４−（（３ｒ，４ｒ）−３−メトキシテトラヒドロ−ピラン−４−イルアミノ）ピペリジン−１−イル）（５−メチル−６−（（（２ｒ，６ｓ）−６−（ｐ−トリル）テトラヒドロ−２ｈ−ピラン−２−イル）メチルアミノ）ピリミジン−４イル）メタノンクエン酸塩
|
|
WO2020250116A1
(en)
|
2019-06-10 |
2020-12-17 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
|
|
JOP20220044A1
(ar)
|
2019-08-28 |
2023-01-30 |
Novartis Ag |
مشتقات 1، 3- فينيل أريل غير متجانسة بها استبدال واستخدامها في معالجة مرض
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
US11629196B2
(en)
|
2020-04-27 |
2023-04-18 |
Incelldx, Inc. |
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
|
